CRT Pilot Study for Children With Heart Failure
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00585065 |
|
Recruitment Status :
Completed
First Posted : January 3, 2008
Last Update Posted : January 11, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Chronic Pediatric Heart Failure | Other: Cardiac Resynchronization Therapy |
| Study Type : | Observational |
| Actual Enrollment : | 7 participants |
| Time Perspective: | Prospective |
| Official Title: | Cardiac Resynchronization Therapy for Children and Adolescents With Advanced Hearth Failure: A Pilot Study |
| Study Start Date : | January 2006 |
| Actual Primary Completion Date : | January 2008 |
| Actual Study Completion Date : | January 2008 |
| Group/Cohort | Intervention/treatment |
|---|---|
| 1 |
Other: Cardiac Resynchronization Therapy
Cardiac Resynchronization Therapy |
- Describe and evaluate clinical and hemodynamic effects of CRT using BVP in children and adolescents with advanced heart failure [ Time Frame: Jan 2006-Jan 2009 ]
- Describe the relationships between ECG measures of mechanical dyssynchrony and subject response to CRT in children and adolescents with advanced heart failure [ Time Frame: Jan 2006-Jan 2009 ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 1 Year to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Chronic and severe heart failure, NYHA class III or IV
- Pts optimized and stable on diuretics and afterload reducing agents (with or without inotropes) for at least 1 week prior to enrollment
- Chronic systemic ventricular dysfunction as defined in the protocol.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00585065
| United States, Utah | |
| University of Utah | |
| Salt Lake City, Utah, United States, 84112 | |
| Principal Investigator: | Elizabeth Saarel, MD | University of Utah |
| Responsible Party: | University of Utah |
| ClinicalTrials.gov Identifier: | NCT00585065 |
| Other Study ID Numbers: |
00015291 IRB#: 00015291 |
| First Posted: | January 3, 2008 Key Record Dates |
| Last Update Posted: | January 11, 2016 |
| Last Verified: | January 2016 |
|
Heart Failure Heart Diseases Cardiovascular Diseases |

